Hem › Myasthenia gravis › Michigan
Kliniska studier för Myasthenia gravis i Michigan
12 studier för Myasthenia gravis söker deltagare vid platser i Michigan.
Städer i Michigan
Officiell studietext (engelska)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Henry Ford Hospital, Detroit
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07217587ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Henry Ford Health System, Detroit
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Henry Ford Health Systems, Detroit
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07284420A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, Farmington Hills
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07673744A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06680037Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Dearborn
- Aurinia Investigational Site, Flint
RekryterarFas 1/2
Ålder 18 till 85 · Alla kön · Uppdaterad 3 aug. 2026 · NCT07596901A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- C.S. Mott Children's Hospital, Ann Arbor
RekryterarFas 2/3
Ålder 2 till 17 · Alla kön · Uppdaterad 31 juli 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1026, Detroit
- Site Number - 1005, East Lansing
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 30 juli 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Michigan State University Clinical Center, East Lansing
- Trinity Health - Grand Rapids Hospital, Grand Rapids
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 juni 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Karmanos Cancer Institute, Detroit
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Lansing
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 18 feb. 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Henry Ford Health System, Detroit
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 feb. 2026 · NCT06298565Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.